The Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

Table 2

Comparison of baseline characteristics among three subgroups.

Parameters	Symptom-resolution group ()		Continuing group ()		Treatment-failure group ()
	Mean	(SD)	Mean	(SD)	Mean	(SD)
Age (years)	75.0	(8.1)	73.8	(6.8)	70.4	(6.8)
PV (ml)	35.3	(13.3)	42.4	(16.3)	40.6	(18.7)
PSA (ng/ml)	2.5	(2.0)	4.7	(10.4)	3.2	(2.4)
IPSS	15.4	(6.8)	15.4	(6.8)	13.8	(4.2)
QOL index	4.2	(1.4)	4.2	(1.4)	4.0	(0.7)
(ml/s)	11.9	(7.6)	11.7	(3.6)	11.7	(7.2)
PVR (ml)	75.7	(79.7)	60.4	(70.2)	74.4	(110.6)

Baseline parameters did not significantly differ between the symptom-resolution group and the continuing group, the symptom-resolution group and treatment-failure group, and the continuing group and the treatment-failure group.